Avail Bio Overview

  • Year Founded
  • 2018

Year Founded

  • Status
  • Out of Business

  • Employees
  • 6

Employees

  • Latest Deal Type
  • Out of Business

Avail Bio General Information

Description

Developer of a novel genomic technology platform intended for therapeutic discovery in immunologic disease. The company's platform combines genomic technology and data science to discover immunologic targets and validate disease biology and mechanisms, enabling researchers to translate novel targets into therapeutic assets.

Contact Information

Website
www.avail.bio
Ownership Status
Out of Business
Financing Status
Formerly VC-backed
Corporate Office
  • 665 3rd Street
  • Room 250
  • San Francisco, CA 94107
  • United States
Primary Industry
Discovery Tools (Healthcare)
Other Industries
Biotechnology
Vertical(s)
Corporate Office
  • 665 3rd Street
  • Room 250
  • San Francisco, CA 94107
  • United States

Want detailed data on 11M+ companies?

What you see here scratches the surface

Request a free trial

Want to dig into this profile?

We’ll help you find what you need

Learn more

Avail Bio Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
3. Out of Business 17-Dec-2025 Completed Out of Business
2. Early Stage VC Completed Generating Revenue
1. Accelerator/Incubator 17-Oct-2018 Completed Generating Revenue
To view Avail Bio’s complete valuation and funding history, request access »

Avail Bio Patents

Avail Bio Recent Patent Activity

Publication ID Patent Title Status First Filing Date Technology (CPC) Citations
WO-2022192402-A1 Methods, compositions, and systems for b-cell isolation sequencing Inactive 10-Mar-2021
GB-202204573-D0 Methods, compositions, and systems for profiling or predicting an immune response Inactive 05-Sep-2019
GB-2605702-A Methods, compositions, and systems for profiling or predicting an immune response Inactive 05-Sep-2019
US-20240230663-A1 Methods, compositions, and systems for profiling or predicting an immune response Inactive 05-Sep-2019
WO-2021046466-A1 Methods, compositions, and systems for profiling or predicting an immune response Inactive 05-Sep-2019 G01N33/6878
To view Avail Bio’s complete patent history, request access »

Avail Bio Signals

Growth Rate

Weekly
Growth
Weekly Growth

Size Multiple

Median
Size Multiple

Key Data Points

Similarweb Unique Visitors

Majestic Referring Domains

PitchBook’s non-financial metrics help you gauge a company’s traction and growth using web presence and social reach.

Request a free trial

Avail Bio FAQs

  • When was Avail Bio founded?

    Avail Bio was founded in 2018.

  • Where is Avail Bio headquartered?

    Avail Bio is headquartered in San Francisco, CA.

  • What is the size of Avail Bio?

    Avail Bio has 6 total employees.

  • What industry is Avail Bio in?

    Avail Bio’s primary industry is Discovery Tools (Healthcare).

  • Is Avail Bio a private or public company?

    Avail Bio is a Private company.

  • What is Avail Bio’s current revenue?

    The current revenue for Avail Bio is .

Data Transparency

  • Meet our data hygiene team

    Discover how our experts ensure you’re getting the most accurate financial data in the industry.

    Read more
  • How PitchBook sources data

    Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.

    Discover our process